News

Isomorphic Labs, a drug discovery company spun out of Google DeepMind, is about to make a historic breakthrough in medicine. The company is gearing up to begin human clinical trials for drugs designed ...
One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...
Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a ...
Isomorphic Labs is the secretive AI life sciences startup spun out of Google DeepMind with the goal of solving all disease with AI-powered drug discovery. Skip to content. Main Navigation.
As Isomorphic Labs aims its artificial intelligence tools at drug development, it’s setting up a new outpost in the biotech hub of Cambridge.
Isomorphic Labs sets up U.S. presence, with an eye on clinical trials. The Alphabet company, spun off from DeepMind, is hiring a new chief medical officer and adding an office in Cambridge.
About Isomorphic Labs. Isomorphic Labs was founded in 2021, with a mission to transform drug discovery with the power of artificial intelligence, ushering in a new era of biomedical breakthroughs.
Isomorphic Labs was spun out of Google DeepMind, after the tech giant achieved one of the biggest biological breakthroughs in the last 50 years. ...
Isomorphic Labs, together with Google DeepMind, developed and released AlphaFold 3 in May 2024, a revolutionary AI model that can predict the structure and interactions of all of life's molecules ...
Isomorphic Labs is the secretive AI life sciences startup spun out of Google DeepMind with the goal of solving all disease with AI-powered drug discovery. Skip to content. Main Navigation.
Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines. LONDON and BOSTON, June 17, 2025 /PRNewswire ...